ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
7.09
-0.24 (-3.21%)
At close: Nov 18, 2025, 4:00 PM EST
7.25
+0.16 (2.31%)
Pre-market: Nov 19, 2025, 8:59 AM EST
ARS Pharmaceuticals Employees
As of December 31, 2024, ARS Pharmaceuticals had 160 total employees, including 155 full-time and 5 part-time employees. The number of employees increased by 134 or 515.38% compared to the previous year.
Employees
160
Change (1Y)
134
Growth (1Y)
515.38%
Revenue / Employee
$892,325
Profits / Employee
-$500,250
Market Cap
700.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 160 | 134 | 515.38% |
| Dec 31, 2023 | 26 | 6 | 30.00% |
| Dec 31, 2022 | 20 | 11 | 122.22% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SPRY News
- 8 days ago - ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - ARS Pharmaceuticals: What We Learned From Q3 Earnings - Why I Maintain Hold Rating - Seeking Alpha
- 9 days ago - ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray) - GlobeNewsWire
- 15 days ago - ARS Pharma Launches Get neffy® on Us for Patients with Severe Allergic Reactions to Improve Access to neffy (epinephrine nasal spray) - GlobeNewsWire
- 15 days ago - UPDATE -- ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting - GlobeNewsWire
- 16 days ago - ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results - GlobeNewsWire
- 16 days ago - ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting - GlobeNewsWire
- 6 weeks ago - ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® (epinephrine nasal spray) - GlobeNewsWire